Ardelyx, Inc. (ARDX) stock prices updated...

Ardelyx, Inc. stock price

Ardelyx, Inc. latest news:

  • 10/11/2017 14:40:23

    Ardelyx jumps more than 60% after positive study results

    Ardelyx Inc. shares soared more than 60% in after-hours trading Wednesday, after the company reported positive results for a study of a proposed drug. Ardelyx said a second Phase 3 study of tenapanor, a drug targeting irritable bowel syndrome with constipation, reached its primary endpoint and all secondary endpoints, and was well-tolerated by patients. "These results are a game-changer for patients with IBS-C, their treating physicians and for Ardelyx as a company," Ardelyx Chief Executive Mike Raab said in the announcement. The same drug previously failed in a study aimed at using it for kidney disease. Ardelyx shares topped $8.50 in late trading after closing at $5.40.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.

  • 08/31/2017 12:23:40

    BRIEF-Deerfield Management reports a 5.79 pct passive stake in Ardelyx‍​

    * Deerfield Management LP reports a 5.79 pct passive stake in Ardelyx Inc as of August 21 - SEC filing ‍​ Source text: ( Further company coverage:

  • More trends:

    Arena Pharmaceuticals, Inc.ARNA | Ares Capital CorporationARCC | Argo Group International Holdings, Ltd.AGII | Argo Group International Holdings, Ltd.AGIIL | Argos Therapeutics, Inc.ARGS | ARI Network Services, Inc.ARIS | ARIAD Pharmaceuticals, Inc.ARIA | Ark Restaurants Corp.ARKR | ARM Holdings plcARMH | Arotech CorporationARTX |